Serum microRNAs/enriched pathways in lung cancer 1-4 years before diagnosis: A pilot study from the HUNT Biobank, Norway.
Oluf Dimitri Røe(Norwegian University of Science and Technology), Vincenzo Lagani(University of Crete), Robin Mjelle(Norwegian University of Science and Technology), Ioannis Tsamardinos(University of Crete), Pål Sætrom(Norwegian University of Science and Technology), Maria Markaki(University of Crete)
Cited by 0
Related Papers
Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment
|Frontiers in Microbiology|2021|390
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
|Journal of Clinical Oncology|2018|229
Shortlasting, Unilateral Neuralgiform Headache Attacks with Conjunctival Injection, Tearing, Sweating, and Rhinorrhea
|Cephalalgia|1989|226
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
|European Respiratory Review|2015|188
A vision and strategy for the virtual physiological human in 2010 and beyond
|Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences|2010|159